A Study of SHR-A1811 in Subjects With Ovarian Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of SHR-A1811 in Subjects With Ovarian Cancer — Stella

Recruiting

Back to Ovarian Cancer trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Qilu Hospital of Shandong University, Jinan, Shandong

Key details

Phase

Large-scale testing

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Enrollment target

~300 participants

Started

March 2025

Primary completion

May 2027

Age range

18 Years – 75 Years

Sex

Female only

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov